Skip to main content
Platelet Rich Plasma Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, China, UK, Japan, Canada, France, India, Australia, South Korea - Size and Forecast 2024-2028

Platelet Rich Plasma Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, China, UK, Japan, Canada, France, India, Australia, South Korea - Size and Forecast 2024-2028

Published: Nov 2024 199 Pages SKU: IRTNTR80404

Market Overview at a Glance

$522.8 Mn
Market Opportunity
15.3%
CAGR
14.2
YoY growth 2023-2024(%)

Platelet Rich Plasma Market Size 2024-2028 

The platelet rich plasma market size is forecast to increase by USD 522.8 billion at a CAGR of 15.3% between 2023 and 2028.

  • The Platelet Rich Plasma (PRP) market is witnessing significant growth due to the increasing incidence of musculoskeletal disorders and the expansion of PRP applications in various fields. PRP, obtained through centrifugation of a patient's own blood, is gaining popularity in cosmetic procedures, such as the Vampire Facial, and tissue repair. In the medical field, PRP is increasingly used in orthopedic surgery for the healing process of chronic tendon injuries and acute ligament injuries. AOA Orthopedic Specialists and other medical institutions are integrating PRP into their treatment plans to enhance patient recovery. However, competition from alternative treatments, such as stem cell therapy and surgical procedures, may challenge the market growth.
  • Despite these challenges, the potential benefits of PRP in improving patient outcomes make it a promising area for future developments. The PRP market is expected to continue its growth trajectory, driven by the increasing demand for minimally invasive treatments and the potential for PRP to address a wide range of medical conditions.

What will be the Size of the Market During the Forecast Period?

Platelet Rich Plasma Market Size

 Request Free Sample

  • An autologous substance derived from a patient's own blood, has gained significant attention in various medical fields due to its potential for tissue repair and regeneration. This article provides an overview of the market. PRP is a low-risk procedure that involves the centrifugation of a patient's blood to isolate and concentrate platelets. These platelets contain growth factors that stimulate collagen production, bone formation, and tissue repair. The applications of PRP span across multiple medical domains, including orthopedics and cosmetic procedures. In the realm of orthopedics, PRP has shown promise in the treatment of various injuries and disorders.
  • For instance, it has been used to aid in post-surgical healing, tendon injuries, muscle injuries, and joint injuries. PRP's ability to stimulate tissue repair makes it a valuable tool for orthopedic surgeons. The cosmetic industry has also embraced PRP as an alternative to traditional cosmetic procedures. Known as Cosmetic PRP, it is used for skin rejuvenation, micro-needling, and vampire facials. These procedures harness the power of PRP to improve skin texture, reduce fine lines, and promote collagen production. PRP's potential revenue streams are diverse. In orthopedics, it is used for both diagnostic and therapeutic purposes, providing opportunities for revenue generation.

How is this market segmented and which is the largest segment?

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

  • Product
    • Pure PRP
    • L-PRP
    • Others
  • End-user
    • Hospitals
    • Specialty clinics
    • Others
  • Geography
    • North America
      • Canada
      • US
    • Europe
      • Germany
      • UK
      • France
    • Asia
      • China
      • India
      • Japan
      • South Korea
    • Rest of World (ROW)

By Product Insights

  • The pure prp segment is estimated to witness significant growth during the forecast period.

Pure Platelet-Rich Plasma (Pure PRP) is a concentration of platelets derived from a patient's blood, primarily used in regenerative medicine for promoting healing and tissue regeneration. The process involves drawing a sample of the patient's blood, which undergoes centrifugation to separate the plasma from other blood components. This centrifugation process concentrates the platelets, leaving behind red and white blood cells. The resulting plasma solution contains a higher concentration of platelets, which are rich in growth factors vital for healing. Pure PRP offers several advantages over traditional PRP preparations due to its two-step centrifugation process. Autologous PRP, allogenic PRP, and homologous PRP are various types of PRP preparations used in medical procedures, including fracture repair, non-healing ulcers, and surgeries in neurosurgery and general surgery.

Pure PRP's enhanced platelet concentration and growth factor content contribute to improved healing outcomes and reduced recovery time. In summary, Pure PRP is a valuable tool in regenerative medicine, offering advantages over traditional PRP preparations through its advanced centrifugation process. This autologous substance plays a crucial role in various medical applications, such as fracture repair, ulcer healing, and surgical procedures in neurosurgery and general surgery.

Platelet Rich Plasma Market Size

Get a glance at the market report of share of various segments Request Free Sample

The Pure PRP segment was valued at USD 153.20 million in 2018 and showed a gradual increase during the forecast period.

Regional Analysis

  • North America is estimated to contribute 39% to the growth of the global market during the forecast period.

Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

Platelet Rich Plasma Market Share by Geography

For more insights on the market share of various regions Request Free Sample

In North America, the Platelet Rich Plasma (PRP) market is experiencing notable expansion due to several significant factors. A substantial contributor to this growth is the rising prevalence of sports injuries and orthopedic disorders. According to the National Hospital Ambulatory Medical Care Survey, around 3.5 million Americans sought emergency department treatment for sports-related injuries in 2023. This high incidence signifies the increasing demand for advanced treatments like PRP, which facilitate faster recovery and enhanced healing outcomes. Moreover, the aging population in North America adds to the market's growth. By 2040, the Centers for Disease Control and Prevention (CDC) projects that approximately 78 million US adults will have arthritis.

This escalating need for innovative treatments to manage chronic conditions underscores the importance of PRP therapies in the region. Additionally, PRP is increasingly being used in cosmetic procedures such as skin rejuvenation, micro-needling, and collagen production enhancement. The popularity of regenerative medicines and treatments, like the Vampire Facial, further boosts the market's expansion. In conclusion, the market in North America is poised for significant growth due to the increasing incidence of sports injuries and orthopedic disorders, an aging population, and the rising popularity of cosmetic procedures.

Market Dynamics

Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage. In cosmetic applications, PRP offers a less invasive alternative to surgical procedures, attracting clients seeking rejuvenation without the downtime associated with surgery. The use of PRP in hair transplants and dental procedures is another growing area. PRP's role in hair loss treatment and bone formation offers significant potential for revenue growth. Despite its advantages, PRP is still considered an investigational procedure in some areas. However, its non-invasive nature and potential for tissue repair make it an attractive option for patients and healthcare providers alike. In conclusion, the market is poised for growth, driven by its versatility and potential for tissue repair and regeneration. Its applications in orthopedics and cosmetics offer diverse revenue streams, making it an essential component of modern medical practices.

What are the key market drivers leading to the rise in adoption of Platelet Rich Plasma Market ?

Increasing incidence of musculoskeletal disorders is the key driver of the market.

  • The Platelet Rich Plasma (PRP) market is experiencing notable growth due to the increasing prevalence of musculoskeletal disorders worldwide. According to recent statistics, over 1.7 billion people were affected by musculoskeletal conditions in 2023, making them the leading cause of disability globally. Musculoskeletal disorders encompass various issues affecting muscles, bones, and connective tissues, including tendons, ligaments, and cartilage repair. These conditions can lead to chronic pain, reduced mobility, and diminished quality of life, necessitating effective treatment options. PRP therapy has gained popularity as a biological treatment for musculoskeletal injuries due to its potential to accelerate healing and shorten recovery times.
  • In the field of orthopedics, PRP has been used to treat injuries in the knee, shoulder, and hip, among others. In dentistry, PRP is used for dental implants and periodontal procedures to improve bone regeneration. Leucocyte-rich PRP, a variant of PRP, is also used in dermatology for skin rejuvenation and wound healing. PRP therapy has also found applications in sports medicine for the treatment of sports-related injuries. For instance, it has been used to treat ulcers and other injuries that require non-surgical management. PRP's ability to stimulate tissue repair and regeneration makes it a promising treatment option for various medical conditions.
  • In conclusion, the market is poised for significant growth due to the increasing incidence of musculoskeletal disorders and the potential of PRP therapy to enhance healing and reduce recovery times in various medical applications, including hair transplants, dental uses, bone formation, knee osteoarthritis, orthopedics, dermatology, sports medicine, and ulcer healing.

What are the market trends shaping the Platelet Rich Plasma Market?

Expansion of product line is the upcoming trend in the market.

  • The Platelet Rich Plasma (PRP) market is experiencing notable growth due to the increasing adoption of PRP technologies for various medical and aesthetic applications. PRP Labs, a prominent distributor of EmCyte products in the US, recently expanded its product offerings. On October 21, 2024, they introduced new Plasma Protein Concentrator and Adipose Concentrate Kits, including the EmCyte FC60 (60ml Plasma Protein Concentrating Kit), FC120 (120ml Plasma Protein Concentration Kit), and PK50 Progenikine Adipose Concentrate Kit. These innovative kits cater to the needs of healthcare professionals in the field of PRP procedures. They offer dependable and superior-quality solutions for both tissue repair in orthopedic surgery and cosmetic treatments like the Vampire Facial.
  • These advancements aim to expedite the healing process in chronic tendon injuries and acute ligament injuries, making PRP a valuable tool in the medical community.

What challenges does Platelet Rich Plasma Market face during the growth?

Competition from alternative treatments is a key challenge affecting the market growth.

  • The Platelet Rich Plasma (PRP) market holds promise in various medical applications, particularly in hospitals for investigational procedures. PRP, a low-risk treatment, is gaining popularity in hair loss treatment and post-surgical healing. In orthopedics, PRP is used for tendon injuries, muscle injuries, and joint injuries. Hospitals can explore revenue streams through PRP treatments, as it offers faster recovery and reduced dependence on traditional therapies. However, PRP faces competition from alternative treatments like stem cell therapy and exosome therapy. Stem cells, with their unique regenerative properties, serve as the body's natural repair system, developing into various cell types and maintaining tissue and organ turnover.
  • They are categorized into adult and embryonic stem cells. Stem cell therapy leverages these capabilities to treat a wide range of medical conditions, including orthopedic issues, neurological disorders, cardiovascular diseases, and autoimmune diseases. PRP and cell therapy serve distinct yet complementary roles in the healthcare industry.

Exclusive Customer Landscape

The market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.

Platelet Rich Plasma Market Share by Geography

 Customer Landscape

Key Companies & Market Insights

Companies are implementing various strategies, such as strategic alliances, market forecast , partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

Advancells - Our company specializes in providing platelet-rich plasma (PRP) with an exceptional platelet concentration of up to 9 times the baseline. This advanced PRP solution effectively reduces leukocytes to 0.15 times the baseline and neutrophils to 0.3, ensuring optimal purity for various medical applications. By leveraging innovative technology and rigorous processing techniques, we deliver high-quality PRP that meets the stringent requirements of healthcare professionals and their patients. This cutting-edge PRP offering is a valuable addition to the medical field, enhancing the potential for improved patient outcomes and therapeutic advancements.

The market research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:

  • Advancells
  • AlocuroTM
  • APEX Biologix
  • Arthrex Inc.
  • BLA and Co.
  • Croma-Pharma GmbH
  • Crown Laboratories Inc.
  • Dr PRP USA LLC
  • EmCyte Corp.
  • Garey Orthopedic Medical Group
  • Isto Biologics
  • Johnson and Johnson Inc.
  • Jorgensen Laboratories LLC
  • Juventix Regenerative Medical LLC
  • Regen Lab SA
  • SingHealth Group
  • Zimmer Biomet Holdings Inc.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Research Analyst Overview

Platelet Rich Plasma (PRP), an autologous substance derived from a patient's own plasma, has gained significant attention in various medical fields due to its potential for tissue repair and recovery of injuries. In orthopedics, PRP is used for the treatment of sports injuries, orthopedic disorders, and musculoskeletal conditions, including knee osteoarthritis, tendon injuries, and joint injuries. PRP's ability to stimulate collagen production and bone formation makes it an effective tool in orthopedic surgery and non-surgical management. In dermatology and cosmetic surgery, PRP is utilized for skin rejuvenation, wrinkle treatment, scarring, and hair growth. The process involves centrifugation of a patient's blood to separate the platelets, which are then reintroduced into the body at the site of injury or treatment area.

PRP has also found applications in dental uses, ulcer healing, and investigational procedures in general surgery, neurosurgery, and plastic surgery. PRP's low-risk procedure and non-surgical nature make it an attractive option for patients seeking alternative methods for healing and recovery. Revenue streams for PRP include orthopedic treatment, cosmetic PRP, and dental surgery. PRP's potential for tissue repair and bone regeneration continues to expand, with ongoing research exploring its applications in chronic tendon injuries, acute ligament injuries, fractures, and non-healing ulcers.

Market Scope

Report Coverage

Details

Page number

199

Base year

2023

Historic period

2018-2022

Forecast period

2024-2028

Growth momentum & CAGR

Accelerate at a CAGR of 15.3%

Market growth 2024-2028

USD 522.8 million

Market structure

Fragmented

YoY growth 2023-2024(%)

14.2

Key countries

US, Germany, China, UK, Japan, Canada, France, India, Australia, and South Korea

Competitive landscape

Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks

Request Free Sample

What are the Key Data Covered in this Market Research and Growth Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the market growth and forecasting between 2024 and 2028
  • Precise estimation of the size of the market  and its contribution of the market in focus to the parent market
  • Accurate predictions about upcoming market growth and trends and changes in consumer behaviour
  • Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
  • Thorough analysis of the market's competitive landscape and detailed information about companies
  • Comprehensive analysis of factors that will challenge the growth of market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

Table of Contents not available.

Research Methodology

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

INFORMATION SOURCES

Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases

DATA ANALYSIS

Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts

REPORT WRITING

Qualitative

  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis

Quantitative

  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape

Interested in this report?

Get your sample now to see our research methodology and insights!

Download Now

Frequently Asked Questions

Platelet Rich Plasma market growth will increase by $ 522.8 mn during 2024-2028.

The Platelet Rich Plasma market is expected to grow at a CAGR of 15.3% during 2024-2028.

Platelet Rich Plasma market is segmented by Product( Pure PRP, L-PRP, Others) End-user( Hospitals, Specialty clinics, Others)

Advancells, AlocuroTM, APEX Biologix, Arthrex Inc., BLA and Co., Croma-Pharma GmbH, Crown Laboratories Inc., Dr PRP USA LLC, EmCyte Corp., Garey Orthopedic Medical Group, Isto Biologics, Johnson and Johnson Inc., Jorgensen Laboratories LLC, Juventix Regenerative Medical LLC, Regen Lab SA, SingHealth Group, Zimmer Biomet Holdings Inc. are a few of the key vendors in the Platelet Rich Plasma market.

North America will register the highest growth rate of 39% among the other regions. Therefore, the Platelet Rich Plasma market in North America is expected to garner significant business opportunities for the vendors during the forecast period.

US, Germany, China, UK, Japan, Canada, France, India, Australia, South Korea

  • Increasing incidence of musculoskeletal disordersThe global platelet rich plasma market is significantly driven by the rising incidence of musculoskeletal disorders. In 2023 is the driving factor this market.
  • approximately 1.7 billion people worldwide were affected by musculoskeletal conditions is the driving factor this market.
  • making them the leading cause of disability globally. Among these conditions is the driving factor this market.
  • low back pain stands out as the single most prevalent cause of disability in 160 countries is the driving factor this market.
  • highlighting the widespread impact of these disorders.Musculoskeletal conditions encompass a range of issues affecting the body muscles is the driving factor this market.
  • bones is the driving factor this market.
  • and connective tissues is the driving factor this market.
  • including tendons is the driving factor this market.
  • ligaments is the driving factor this market.
  • and cartilage. These conditions often result in chronic pain is the driving factor this market.
  • reduced mobility is the driving factor this market.
  • and diminished quality of life is the driving factor this market.
  • necessitating effective treatment options. PRP therapy has emerged as a popular biological treatment for various musculoskeletal injuries due to its potential to enhance healing and reduce recovery times.PRP therapy involves the extraction of a small amount of the patient blood is the driving factor this market.
  • which is then processed to concentrate the platelets. These platelets are rich in growth factors that promote tissue repair and regeneration. When injected into the affected area is the driving factor this market.
  • PRP can stimulate the healing of tendons is the driving factor this market.
  • ligaments is the driving factor this market.
  • cartilage is the driving factor this market.
  • and bone is the driving factor this market.
  • making it a versatile treatment for a wide range of musculoskeletal injuries.The increasing prevalence of musculoskeletal disorders is driving the demand for PRP treatments. Patients and healthcare providers are increasingly shifting to PRP as a non-surgical alternative that can offer significant pain relief and functional improvement. The ability of PRP to harness the natural healing processes of the body makes it an attractive option for those seeking to avoid the risks and recovery times associated with surgical interventions.As the number of individuals affected by these conditions continues to rise is the driving factor this market.
  • the demand for effective is the driving factor this market.
  • non-invasive treatments such as PRP is expected to increase. This trend underscores the importance of PRP therapy in addressing the significant burden of musculoskeletal disorders and improving patient outcomes worldwide. is the driving factor this market.

The Platelet Rich Plasma market vendors should focus on grabbing business opportunities from the Pure PRP segment as it accounted for the largest market share in the base year.